Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New technique for detecting cardiac fibrosis

21.03.2002


A medical team of the Basque Country has discovered a new technique to detect cardiac fibrosis. After a research carried out during several years, it has been discovered that serum leves of PIP peptide is an indicator of increased myocardial fibrosis.



Fibrosis is formed when scar tissue is accumulated in heart. As a consequence it causes stiffening of the heart and often heart failure. In order to fight against such disease, researchers started looking for an indicator substance in blood.

Collagen amount and PIP


This research started 10 years ago with spontaneoulsy hypertensive rats. As a result, they could find out that hypertensive disease increases the amount of heart collagen. On the other hand, researchers did know that in some other diseases, like cirrhosis of the liver, collagen amount used to increase. It was also well known that in such disease the serum amount of PIP substance (carboxyterminal peptide of type 1 procollagen) was high. Hence, could it be possible that this peptide shows also which patientes are accumulating too much scar tissue in the heart?

The research carried out in rats confirmed that. The amount of peptide was clearly higher in those rats who had abnormal myocardial fibrosis than in those who did not. However, the result had to be tested in human beings. To do that, they did blood analysis and endomyocardial biopsies in hypertensive patients and found that in these patients myocardial collagen content was 4-5 times higher than in normotensive subjects and was closely correlated with serum levels of PIP.

Successful results

This new indicator, PIP substance, can successfully detect fibrosis in 80% of the cases. That is a great step forward considering the detection rate of the existing techniques. Now, in order to apply this technique, measures of PIP must be carried out in more patients. However, it has been proved that cardiac fibrosis is caused by hypertension and that it can be detected thanks to PIP peptide.

Moreover, analysing treatments to lower high blood pressure, they find out that some of the used medications which counteract the effects of a substance called angiotensin II, had a backward effect on fibrosis. This backward effect was observed in PIP substance aswell. Therefore, apart from indicating the presence of the disease and showing its severity, it may be used to assess the capability of antihipertensive medications to repare myocardial structure.

Future researches will be focused on physiological and pathological relationship between heart failure, fibrosis and high blood pressure. Then it may be possible to find prevention pathways of heart failure, which is widely prevalent in our age-increasing society.

Carton Eider | alphagalileo

More articles from Health and Medicine:

nachricht Spread of deadly eye cancer halted in cells and animals
13.11.2018 | Johns Hopkins Medicine

nachricht Breakthrough in understanding how deadly pneumococcus avoids immune defenses
13.11.2018 | University of Liverpool

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

Im Focus: Coping with errors in the quantum age

Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly

The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

The dawn of a new era for genebanks - molecular characterisation of an entire genebank collection

13.11.2018 | Life Sciences

Fish recognize their prey by electric colors

13.11.2018 | Life Sciences

Ultrasound Connects

13.11.2018 | Awards Funding

VideoLinks
Science & Research
Overview of more VideoLinks >>>